Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce W Bode

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Diabetes Technology & Therapeutics|December 27, 2018
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 DiabetesGregory P Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, et al.
Diabetes, Obesity & Metabolism|January 9, 2026
Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-studyJean-Pierre Riveline, Eric Renard, Grazia Aleppo, et al.
Diabetes Care|June 26, 2018
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 StudyJohn B Buse, Satish K Garg, Julio Rosenstock, et al.
Diabetes Technology & Therapeutics|February 6, 2025
Safety and Effectiveness of MiniMed<sup>TM</sup> 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 DiabetesAnuj Bhargava, Richard M Bergenstal, Mark L Warren, et al.
Diabetes Care|October 18, 2024
Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical TrialEric Renard, Ruth S Weinstock, Grazia Aleppo, et al.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Nature Medicine|October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Nature Medicine|March 18, 2023
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
JCI Insight|December 20, 2019
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetesKevan C Herold, Samantha L Bucktrout, Xiao Wang, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Diabetes Technology & Therapeutics|December 27, 2018
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 DiabetesGregory P Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, et al.
Diabetes, Obesity & Metabolism|January 9, 2026
Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-studyJean-Pierre Riveline, Eric Renard, Grazia Aleppo, et al.
Diabetes Care|June 26, 2018
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 StudyJohn B Buse, Satish K Garg, Julio Rosenstock, et al.
Diabetes Technology & Therapeutics|February 6, 2025
Safety and Effectiveness of MiniMed<sup>TM</sup> 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 DiabetesAnuj Bhargava, Richard M Bergenstal, Mark L Warren, et al.
Diabetes Care|October 18, 2024
Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical TrialEric Renard, Ruth S Weinstock, Grazia Aleppo, et al.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Nature Medicine|October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Nature Medicine|March 18, 2023
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
JCI Insight|December 20, 2019
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetesKevan C Herold, Samantha L Bucktrout, Xiao Wang, et al.
Pageof 13